JoJoJun 5, 20181 min readSalvia BioelectronicsOriginally posted May 2018Hubert Martens and Michel Decré rake in €1.3m seed funding to develop minimally invasive #BioelectronicMedicine solutions for chronic neurological disease.Salvia Bioelectronics#chronic #Funding #Investement #Neurologicaldisease1 view0 commentsPost not marked as liked
Originally posted May 2018Hubert Martens and Michel Decré rake in €1.3m seed funding to develop minimally invasive #BioelectronicMedicine solutions for chronic neurological disease.Salvia Bioelectronics#chronic #Funding #Investement #Neurologicaldisease
